The first CRISPR therapy approved in the U.S. will treat sickle cell disease

In the world’s first CRISPR-based treatment, genetic tweaks to red blood cells aim to help people with the often debilitating disease.

Related Keywords

New York ,United States ,United Kingdom ,Cambridge ,Cambridgeshire ,David Altshuler ,William Hobbs ,Kerry Morrone ,Jimi Olaghere ,Albert Einstein College Of Medicine ,Drug Administration ,Sickle Cell Program ,Vertex Pharmaceuticals ,Nobel Prize ,Boston Based Vertex Pharmaceuticals ,Albert Einstein College ,Victoria Gray ,